Back

PCSK9 inhibitors use in clinical practice: a tertiary hospital experience

12 April 2019 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Risk Factors and Prevention - Lipids Lipids EAPC Premium Access EuroPrevent 2019

About the speaker

Photo
Doctor Lorena Martin Polo

Madrid Hospital Group: HM Hospitales, Madrid (Spain)

15 More presentations in this session

Presentation thumbnail
Doctor L. Kitova (Plovdiv, BG)
Presentation thumbnail
Doctor S. Cardoso Torres (Porto, PT)
Abstract
Presentation thumbnail
Professor N. Pogosova (Moscow, RU)
Abstract
Presentation thumbnail
Doctor E. Kolesova (St Petersburg, RU)
Abstract
Presentation thumbnail
Doctor J. Gilis-Januszewski (Bad Oeynhausen, DE)
Abstract

Access the full session

Session thumbnail
Poster Session 2 - Risk Factors and Prevention - Lipids

The Event

Event poster

EuroPrevent 2019

12 April 2019 08:30 CET
You may be interested in
thumbnail
Congress Presentation
PCSK9 inhibitors: effectiveness of treatment and changes in background lipid-lowering therapy in a real world Italian population. The AT-TARGET-IT study
26 August 2022
thumbnail
Webinar
Post-ACS management of dyslipidaemia: tips and tricks from real world experiences
16 December 2020
thumbnail
Congress Presentation
Association between PCSK9 inhibitor with cause-specific morality amongst cancer survivors
1 September 2024
thumbnail
Webinar
Injectable therapies for cardiovascular disease: optimising their use in practice - experiences from the UK and Italy
18 March 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources